At a glance
- Originator Pfizer
- Class Antibacterials
- Mechanism of Action DNA gyrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycobacterium avium complex infections
Most Recent Events
- 21 Jun 2000 Warner-Lambert has merged with Pfizer
- 27 May 1997 New profile
- 27 May 1997 Preclinical development for Mycobacterium avium complex infections in USA (Unknown route)